Metabolic Risk Factors and Ursodiol Response in Primary Biliary Cholangitis

被引：0

作者：

Zouridis, Spyridon ^{[1
]}

Nguyen, Khang ^{[2
]}

Lee, Felicia ^{[2
]}

Qureshi, Kamran ^{[2
]}

机构：

[1] SSM Hlth St Louis Univ Hosp, St Louis, MO USA

[2] St Louis Univ, Sch Med, St Louis, MO USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期

关键词：

D O I：

10.14309/01.ajg.0001036884.76550.3a

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1879

引用

页码：S1350 / S1351

页数：2

共 50 条

[1] Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome
Braga, Michelle Harriz
Lopes Cancado, Guilherme Grossi
Bittencourt, Paulo Lisboa
Couto, Claudia Alves
Guedes, Laura Vilar
Costa Lima, Andre Mourao
Gomes Ferraz, Maria Lucia
Villela-Nogueira, Cristiane Alves
Nardelli, Mateus Jorge
Faria, Luciana Costa
de Faria Gomes, Nathalia Mota
Gomes Oliveira, Elze Maria
Rotman, Vivian
Oliveira, Maria Beatriz
Carvalho Fernandes da Cunha, Simone Muniz
Cunha-Silva, Marlone
Costa Mendes, Liliana Sampaio
Pontes Ivantes, Claudia Alexandra
Codes, Liana
de Almeida e Borges, Valeria Ferreira
de Lima Pace, Fabio Heleno
Pessoa, Mario Guimaraes
Signorelli, Izabelle Venturini
Coral, Gabriela Perdomo
Galizzi Filho, Joao
Chagas, Aline Lopes
Benedita Terrabuio, Debora Raquel
Rachid Cancado, Eduardo Luiz
ANNALS OF HEPATOLOGY, 2023, 28 (04)
[2] Ursodiol for primary sclerosing cholangitis
Lindor, KD
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (10): : 691 - 695
[3] PRIMARY SCLEROSING CHOLANGITIS (PSC) - RESPONSE TO COMBINATION METHOTREXATE AND URSODIOL
KAPLAN, MM
KNOX, TA
HEPATOLOGY, 1991, 14 (04) : A194 - A194
[4] RESPONSE TO URSODIOL THERAPY IN REDUCING ALKALINE PHOSPHATASE TO NORMAL LEVELS IN PRIMARY BILIARY CHOLANGITIS IN A DIVERSE COMMUNITY PRACTICE
Mueller, Austin
Jafri, Syed-Mohammed
HEPATOLOGY, 2023, 78 : S2071 - S2072
[5] Predicting Risk in Primary Biliary Cholangitis
Eksteen, Bertus
HEPATOLOGY, 2016, 63 (03) : 697 - 699
[6] Risk Stratification in Primary Biliary Cholangitis
Martini, Francesco
Balducci, Daniele
Mancinelli, Martina
Buzzanca, Valerio
Fracchia, Elena
Tarantino, Giuseppe
Benedetti, Antonio
Marzioni, Marco
Maroni, Luca
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (17)
[7] Predicting Risk in Primary Biliary Cholangitis
Cho, Eun Ju
GUT AND LIVER, 2023, 17 (04) : 491 - 492
[8] Identification of Risk Factors for Histological Progression in Patients with Primary Biliary Cholangitis
Namisaki, Tadashi
Okura, Yasushi
Kaji, Kosuke
Kitade, Mitsuteru
Shimozato, Naotaka
Moriya, Kei
Sato, Shinya
Kawaratani, Hideto
Takaya, Hiroaki
Sawada, Yasuhiko
Seki, Kenichiro
Nakanishi, Keisuke
Furukawa, Masanori
Tsuji, Yuki
Fujinaga, Yukihisa
Akahane, Takemi
Asada, Kiyoshi
Yoshiji, Hitoshi
HEPATOLOGY, 2018, 68 : 1017A - 1018A
[9] Identification of clinical risk factors for histological progression of primary biliary cholangitis
Fujinaga, Yukihisa
Namisaki, Tadashi
Moriya, Kei
Kitade, Mitsuteru
Kawaratani, Hideto
Shimozato, Naotaka
Kaji, Kosuke
Takaya, Hiroaki
Sawada, Yasuhiko
Seki, Kenichiro
Akahane, Takemi
Okura, Yasushi
Sato, Shinya
Saikawa, Soichiro
Nakanishi, Keisuke
Kubo, Takuya
Furukawa, Masanori
Kitagawa, Koh
Ozutsumi, Takahiro
Tsuji, Yuki
Kaya, Daisuke
Mashitani, Tsuyoshi
Ishida, Koji
Ogawa, Hiroyuki
Takagi, Hirotetsu
Noguchi, Ryuichi
Mitoro, Akira
Yamao, Junichi
Yoshiji, Hitoshi
HEPATOLOGY RESEARCH, 2019, 49 (09) : 1015 - 1025
[10] Prevalence and prognostic significance of main metabolic risk factors in primary biliary cholangitis: a retrospective cohort study of 789 patients
Zhao, Dan-Tong
Yan, Hui-Ping
Han, Ying
Zhang, Wei-Ming
Zhao, Yan
Liao, Hui-Yu
FRONTIERS IN ENDOCRINOLOGY, 2023, 14

← 1 2 3 4 5 →